Abstract
Chronic inflammatory diseases such as rheumatoid arthritis (RA), Juvenile Idiopathic Arthritis (JIA), psoriasis, and inflammatory bowel disease (IBD) are characterized by systemic as well as local tissue inflammation, often with a relapsing-remitting course. Tissue-resident memory T cells (T(RM)) enter non-lymphoid tissue (NLT) as part of the anamnestic immune response, especially in barrier tissues, and have been proposed to fuel chronic inflammation. T(RM) display a distinct gene expression profile, including upregulation of CD69 and downregulation of CD62L, CCR7, and S1PR1. However, not all T(RM) are consistent with this profile, and it is now more evident that the T(RM) compartment comprises a heterogeneous population, with differences in their function and activation state. Interestingly, the paradigm of T(RM) remaining resident in NLT has also been challenged. T cells with T(RM) characteristics were identified in both lymph and circulation in murine and human studies, displaying similarities with circulating memory T cells. This suggests that re-activated T(RM) are capable of retrograde migration from NLT via differential gene expression, mediating tissue egress and circulation. Circulating 'ex-T(RM)' retain a propensity for return to NLT, especially to their tissue of origin. Additionally, memory T cells with T(RM) characteristics have been identified in blood from patients with chronic inflammatory disease, leading to the hypothesis that T(RM) egress from inflamed tissue as well. The presence of T(RM) in both tissue and circulation has important implications for the development of novel therapies targeting chronic inflammation, and circulating 'ex-T(RM)' may provide a vital diagnostic tool in the form of biomarkers. This review elaborates on the recent developments in the field of T(RM) in the context of chronic inflammatory diseases.